Risk factors associated with HIV seropositivity among STD patients in 18 European surveillance networks
The European Study Group
IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 95
1993
Accession: 033250138
PDF emailed within 1 workday: $29.90
Related References
Buchheidt, D.; Hiddemann, W.; Schiel, X.; Kremery, V.; Karthaus, M.; Donnelly, J.P.; Wilhelm, M.; Maschmeyer, G.; Link, H.; Adam, D.; Helmerking, M. 1999: European surveillance of infections and risk factors in cancer patients European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 18(2): 161-163Alary, M.; Castel, J. 1990: Risk factors for HIV seropositivity among people consulting for HIV antibody testing: a pilot surveillance study in Quebec Cmaj: Canadian Medical Association Journal 143(1): 25-31
Kim, C.-J.; Choi, W.S.; Jung, Y.; Kiem, S.; Seol, H.Y.; Woo, H.J.; Choi, Y.H.; Son, J.S.; Kim, K.-H.; Kim, Y.-S.; Kim, E.S.; Park, S.H.; Yoon, J.H.; Choi, S.-M.; Lee, H.; Oh, W.S.; Choi, S.-Y.; Kim, N.-J.; Choi, J.-P.; Park, S.Y.; Kim, J.; Jeong, S.J.; Lee, K.S.; Jang, H.C.; Rhee, J.Y.; Kim, B.-N.; Bang, J.H.; Lee, J.H.; Park, S.; Kim, H.Y.; Choi, J.K.; Wi, Y.-M.; Choi, H.J. 2016: Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 22(10): 880-8
Ammon, A. 2005: Structure of the Surveillance and management of infectious diseases in the European Union. The EU surveillance networks and the European Centre for Disease Prevention und Control (ECDC) Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 48(9): 1038-1042
Grossi, M.A.d.F.; Leboeuf, M.A.A.új.; Andrade, A.R.C.d.; Bührer-Sékula, S.; Antunes, C.M.íc.d.F. 2008: Risk factors for ML Flow seropositivity in leprosy patients Revista da Sociedade Brasileira de Medicina Tropical 41(Suppl 2): 39-44
Pedhambkar, R.B.; Pedhambkar, B.S.; Kura, M.M. 2001: Study of risk factors associated with HIV seropositivity in STD patients at Mumbai, India Sexually Transmitted Infections 77(5): 388-389
Rouhani-Rankouhi, S.Z.; Kow, K.S.; Liam, C.K.; Lau, Y.L. 2020: Seropositivity and risk factors of Toxocara canis infection in adult asthmatic patients Tropical Biomedicine 37(3): 599-608
Grant, R.; Aupee, M.; Buchs, N.C.; Cooper, K.; Eisenring, M-Christine.; Lamagni, T.; Ris, Fédéric.; Tanguy, J.; Troillet, N.; Harbarth, S.; Abbas, M. 2019: Performance of surgical site infection risk prediction models in colorectal surgery: external validity assessment from three European national surveillance networks Infection Control and Hospital Epidemiology 40(9): 983-990
Sinn, D.H.; Yi, J.; Choi, M.S.; Choi, D.; Gwak, G.-Y.; Paik, Y.-H.; Lee, J.H.; Koh, K.C.; Paik, S.W.; Yoo, B.C. 2013: Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance Hepatology International 7(4): 1010-1018
Lefebvre, N.; Falzon, D. 2008: Risk factors for death among tuberculosis cases: analysis of European surveillance data European Respiratory Journal 31(6): 1256-1260
Ohki, T.; Tateishi, R.; Goto, E.; Sato, T.; Masuzaki, R.; Imamura, J.; Goto, T.; Kanai, F.; Kato, N.; Shiina, S.; Yoshida, H.; Kawabe, T.; Omata, M. 2010: Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors Journal of Viral Hepatitis 17(2): 91-97
Yavuz, M.T.; Yavuz, O.; Yazici, M.; Guler, S.; Ozhan, H.; Albayrak, S.; Coskun, A. 2006: Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis Scandinavian Journal of Clinical and Laboratory Investigation 66(6): 523-534
Kılıç, Z.B.; Poyraz, O.; Kılıç, A.T. 2012: Investigation of Chlamydophila pneumoniae seropositivity and risk factors in patients with atherosclerotic vascular disease in Sivas, Turkey Mikrobiyoloji Bulteni 46(1): 156-158
Zerr, I.; Brandel, J.P.; Masullo, C.; Wientjens, D.; de Silva, R.; Zeidler, M.; Granieri, E.; Sampaolo, S.; van Duijn, C.; Delasnerie-Lauprêtre, N.; Will, R.; Poser, S. 2000: European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors Journal of Clinical Epidemiology 53(7): 747-754
Eshetu, D.; Shimelis, T.; Nigussie, E.; Shumie, G.; Chali, W.; Yeshitela, B.; Assefa, A.; Gadisa, E. 2020: Seropositivity to dengue and associated risk factors among non-malarias acute febrile patients in Arba Minch districts, southern Ethiopia Bmc Infectious Diseases 20(1): 639